Real-time enrollment status for this advanced solid tumor clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 7:10 PM UTC
| NCT Number | NCT06974110 |
| Recruiting Status | Recruiting |
| Condition | Advanced Solid Tumor |
| Phase | PHASE1 |
| Target Enrollment | 132 participants |
| Active Locations | 9 sites in the US |
| Sponsor | MOMA Therapeutics |
| Last Updated on CT.gov | July 23, 2026 (Jul 23, 2026) |
As of August 27, 2026: Clinical trial NCT06974110 is currently recruiting participants. This phase1 study for advanced solid tumor is actively seeking new participants at 9 locations across the United States. The study is sponsored by MOMA Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06974110 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 9 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06974110 was last updated Jul 23, 2026 (July 23, 2026). HelloStudys verifies this status automatically.